Ekf Diagnostics Sustainability Profile
Ekf Diagnostics, officially known as EKF Diagnostics Holdings plc, is a prominent player in the global diagnostics industry, headquartered in Great Britain. Founded in 2000, the company has established itself as a leader in point-of-care testing and laboratory diagnostics, with a strong operational presence across Europe, North America, and Asia. Specialising in innovative products such as blood glucose monitoring systems, haemoglobin analysers, and molecular diagnostics, EKF Diagnostics is recognised for its commitment to quality and accuracy. The company’s unique approach combines advanced technology with user-friendly designs, catering to the needs of healthcare professionals and patients alike. With a solid market position, EKF Diagnostics has achieved significant milestones, including strategic partnerships and a growing portfolio of patented technologies, solidifying its reputation as a trusted provider in the healthcare sector.
DitchCarbon Score
How does Ekf Diagnostics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ekf Diagnostics's score of 25 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ekf Diagnostics's reported carbon emissions
In 2023, EKF Diagnostics, headquartered in Great Britain, reported total carbon emissions of approximately 473,000 kg CO2e. This figure includes 79,000 kg CO2e from Scope 1 emissions (mobile combustion) and 20,000 kg CO2e from stationary combustion, alongside 374,000 kg CO2e from Scope 2 emissions related to purchased electricity. Comparatively, in 2022, the company recorded total emissions of about 338,000 kg CO2e, with Scope 1 emissions at 21,000 kg CO2e (mobile combustion: 21,000 kg CO2e; stationary combustion: 25,000 kg CO2e) and Scope 2 emissions at 292,000 kg CO2e. This indicates a significant increase in emissions from 2022 to 2023. EKF Diagnostics has not set specific reduction targets or climate pledges, and there are no reported initiatives under the Science Based Targets initiative (SBTi). The company does not disclose Scope 3 emissions, which typically encompass indirect emissions in the value chain. All emissions data is sourced directly from EKF Diagnostics Holdings plc, with no cascaded data from parent or related organizations. The company continues to monitor its carbon footprint as part of its operational strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | |
|---|---|
| Scope 1 | 46,181,000 |
| Scope 2 | 291,808,000 |
| Scope 3 | - |
How Carbon Intensive is Ekf Diagnostics's Industry?
How Carbon Intensive is Ekf Diagnostics's Location?
Ekf Diagnostics's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Ekf Diagnostics has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
